CyrusHedvatMDPhD

Pathology • New York, NY

Hematopathology, Molecular Genetics, Anatomic Pathology, Surgical Pathology

Associate Director, Computational and Systems Pathology

Join to view full profile

Dr. Hedvat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hedvat's full profile

Already have an account?

Office
1 Gustave Levy Pl
New York, NY 10029

Education & Training

Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 1999
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1996 - 1998
Georgetown University School of MedicineClass of 1996

Certifications & Licensure

NY State Medical License 2001 - 2025
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.
Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer
Journal for Immunotherapy of Cancer. 2025-01-08
6 citations
Development of a LAG-3 immunohistochemistry assay for melanoma.
Lori Johnson, Bryan McCune, Darren Locke, Cyrus Hedvat, John B Wojcik
Journal of Clinical Pathology. 2023-09-01
151 citations
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Janis M. Taube, Guray Akturk, Michael Angelo, Elizabeth L. Engle, Sacha Gnjatic
Journal for Immunotherapy of Cancer. 2020-05-01

Grant Support

Role Of Myeloid ELF-1 LIKE Factor In HematopoiesisNational Heart, Lung, And Blood Institute2001–2005